Jump to content
African American Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE
  • entries
    277
  • comments
    0
  • views
    609

Entries in this blog

The contract regulatory affairs-management services market for medical devices is estimated to be worth USD 820 million by 2030, growing at a CAGR of 6.9%, claims Roots Analysis

Over the years, outsourcing has become a popular trend with the medical device industry, allowing innovators to leverage the technical and regulatory expertise of contract service providers in order to expedite time to market   Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CROs for Regulatory Affairs Management Market, 2019-2030.”   The report features a detailed study on the current landscape of contract service providers

Damon Salvatore

Damon Salvatore in Health & Fitness

The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030

Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals   Roots Analysis is pleased to announce the publication of its recent study, titled “Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030” report to its list of offerings.   The report provides

The global, handheld X-ray imaging devices market is projected to be worth USD 2.8 billion by 2030, growing at a CAGR of 12%, claims Roots Analysis

Besides portability, handheld X-ray scanners offer a wide range of benefits, including cost savings; in the initial days of the pandemic, such devices were instrumental in increasing diagnostic throughput since they could be easily sterilized   Roots Analysis has announced the addition of “Global Handheld X-Ray Imaging Devices Market by Area of Application (Dental and Others), Device Class (Low-End, Mid-End and High-End), End-Users (Ambulatory Surgical Centers, Diagnostic Imaging Cente

The gene therapy market is characterized by a healthy drug pipeline, with 10 approved molecules and over 820 product candidates {Roots Analysis}

Success of approved gene therapies has resulted in a surge in interest of biopharmaceutical developers in this rapidly evolving domain. Presently, the ability of gene therapies to treat diverse disease indications is considered among the most prominent drivers of this market. In addition, promising clinical results of pipeline candidates are anticipated to draw in more investments to support product development initiatives.   To order this 720+ page report, which features 220+ figures

The gene therapy market is projected to grow at an annualized rate of 30%, {till 2030}

Roots Analysis has done a detailed study on Gene Therapy Market (4th Edition), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 720+ page report, which features 220+ figures and 375+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/gene-therapies-market/268.html   Key Market Insights §  The gene therapy market is characterized by a healthy drug pipeline, with

The gene therapy market is estimated to be worth USD 14.6 billion in 2030, predicts {Roots Analysis}

Given their potential to treat rare, inherited diseases, as well as those previously deemed incurable, the field of gene therapy has gained significant traction in the last few years   Roots Analysis is pleased to announce the publication of its recent study, titled, “Gene Therapy Market (4th Edition), 2020-2030”.   The report features an extensive study of the current market landscape of gene therapies, primarily focusing on gene augmentation-based therapies, oncolytic viral

Close to 50 companies are offering a variety of analytical testing solutions for the assessment of novel cancer biomarkers, {Roots Analysis}

Over time, pharmaceutical players have demonstrated significant interest in this domain and have launched clinical research initiatives to investigate the relevance and applications of these novel biomarkers. Several companies have already developed / are developing analytical tests for novel cancer biomarkers (TMB, MSI / MMR and TILs), intended to assist physicians in making personalized treatment decisions.   To order this 370+ page report, which features 190+ figures and 180+ tables

Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts {Roots Analysis}

Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions   Roots Analysis is pleased to announce the publication of its recent study, titled, “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019–2030.”   The report features an extensive study of the current landscape an

[Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030]

To order this 350+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html   Key Inclusions §  A detailed review of the overall landscape of the non-invasive cancer diagnostics market, featuring information on the developers of such products and analyses based on a number of relevant parameters, such as year of establishment, company size, geographical location, current development status of proprietary liquid bio

Nearly 300 non-invasive diagnostic tests, are either already available in the market or under development across the world.

Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics that are capable of offering highly accurate, and actionable insights related to the disease.   To order this 350+ page report, which features 150+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html   The financial opportunity within the liq

The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030, predicts [Roots Analysis]

Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access   Roots Analysis is pleased to announce the publication of its recent study, titled, “Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes an

The market opportunity for AR / VR based healthcare digital marketing service providers is likely to grow at a CAGR of 26%, till (2030)

Roots Analysis has done a detailed study on “AR / VR based Healthcare Digital Marketing Servicev Providers Market, 2020-2030” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 180+ page report, which features 45+ figures and 70+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html   Key Market Insights §  Presently, more than 120 compani

The market opportunity for AR / VR based healthcare digital marketing service providers is likely to grow at a CAGR of 26%, till (2030)

Over time, many pharma companies have begun incorporating augmented reality (AR) and virtual reality (VR) features, in order to offer an experiential and interactive dimension to their educational / marketing content   Roots Analysis has done a detailed study on “AR / VR based Healthcare Digital Marketing Servicev Providers Market, 2020-2030” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.     The report features an

Report features an extensive study of the potential applications, current landscape and the likely adoption of cobots across various industrial applications.

To order this detailed 245+ page report, please visit this - https://www.rootsanalysis.com/reports/collaborative-robots-market.html   Key Inclusions §  An overview of the current market landscape of cobots, providing information on the market availability (available and under development), industrial task(s) performed (air blowing / spraying, CNC machine tending, gluing / dispensing / welding, loading / unloading, material handling, material removal / processing, packaging, pallet

Over 230 cobots, having variable payload capacities and degrees of freedom, have already been deployed claims Roots Analysis.

Collaborative robots or cobots allow companies to automate their processes, are easy to program and deploy, can increase productivity manifolds, and offer high returns on investment. It is worth noting that, according to the International Federation of Robotics (IFR), over time, the cost of cobots has decreased owing to growing demand for such machines across various industries, including automobiles, electronics / electrical goods, food and beverages, as well as life sciences / pharmaceuticals.

The global collaborative robots (cobots) market is projected to be worth USD 18 billion by 2030, growing at a CAGR of 34.4%.

Given their flexibility and price to functionality ratio, cobots represent an ideal entry-level, automation model for both small and established companies, which do not intend to make very heavy large investments in automation   Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Collaborative Robots (Cobots) Market, 2020-2030.”   The report features an extensive study of the potential applications, current landscape and the likely adopt

Report features an extensive study of the current market landscape "Roots Analysis"

To order this detailed 320+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html   Key Inclusions §  A detailed assessment of the current market landscape of companies offering companion diagnostics services, including information on the type of services offered, type of analytical technique used and regulatory certifications / accreditations, and other company-specific details (such as year of establishment,

The Companion Diagnostics Development Services Market is projected to grow at an annualized rate of ~5%, till 2030.

Roots Analysis has done a detailed report on Companion Diagnostics Development Services Market, 2020-2030 covering key aspects of the industry and identifying future growth opportunities     To order this 320+ page report, which features 120+ figures and 115+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html   Key Market Insights §  Over 180 companies from different regions across the globe prese

The Companion Diagnostics Development Services Market is estimated to be worth over USD 800 million in 2030.

In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise   Roots Analysis is pleased to announce the publication of its recent study, titled, “Companion Diagnostics Development Services Market, 2020-2030”   The report features an extensive study of the current market landscape, offering an info

Offer a wide range of preclinical and clinical research-related services to medical device-focused business entities, claims {Roots Analysis}

Given the complex R&D protocols and the increasing demand for clinical evidence of therapeutic benefit, there seems to be a lucrative opportunity for contract research providers engaged in the medical devices’ domain. In fact, since 2000, 150 new CROs have been established that offer a variety of cost-efficient services and solutions to medical device developers.   To order this 400+ page report, which features 240+ figures and 200+ tables, please visit this - https://www.rootsanal

The medical device CRO market is estimated to be worth USD 15.7 billion in 2030, predicts {Roots Analysis}

Advances in the medical device industry have led to a substantial increase in developmental complexity, clinical trial conduct, and stringency of regulatory review, causing sponsors to rely on the technical and regulatory affairs management expertise of CROs   Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CRO Market (2nd Edition), 2020-2030”.   The report features an extensive study of the current market landscape and futu

Endocannabinoid system targeted therapeutics market {Roots Analysis}

Roots Analysis has done a detailed study on Endocannabinoid System Targeted Therapeutics Market, 2020-2030 “ covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 250+ page report, which features 140+ figures and 170+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html   Key Market Insights §  More than 65 industry players across the world a

Endocannabinoid system targeted therapeutics market is projected to be over USD 5 billion by 2030, predicts {Roots Analysis}

So far, more than 100 different cannabinoids have been identified, and there is a growing body of evidence supporting the clinical benefits of this class of compounds in treating the symptoms of a wide variety of chronic health conditions   Roots Analysis is pleased to announce the publication of its recent study, titled, “Endocannabinoid System Targeted Therapeutics Market, 2020-2030 “   The report features an extensive study of the current market landscape, offering an inf

The endocannabinoid system targeted therapeutics market growing at an annualized rate of 30%, claims {Roots Analysis}

So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence supporting the benefits of this class of compounds in offering symptomatic relief for a wide variety of chronic health conditions   London   Roots Analysis has announced the addition of “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report to its list of offerings.   Over time, extensive R&D on the potential health benefits of can

Targeted protein degradation enabling technologies market predicts {Roots Analysis}

Roots Analysis has done a detailed study on “Targeted Protein Degradation Market, 2021-2030.”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 330+ page report, which features 115+ figures and 180+ tables, please visit this link   Key Market Insights §  Presently, several small molecule protein degraders are being evaluated for the treatment of a wide variety of disease indications; PROTACs is the m
×
  • Create New...